Venrock Healthcare Partners
66
134M
55
1.20
7
0.17
28
- Areas of investment
Summary
The fund has exact preference in a number of founders of portfolio startups. When startup sums 2 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Sojournix, Corvidia, Metacrine.
The typical case for the fund is to invest in rounds with 8 participants. Despite the Venrock Healthcare Partners, startups are often financed by venBio Partners, Polaris Partners, Pappas Ventures. The meaningful sponsors for the fund in investment in the same round are Boxer Capital, RTW Investments LLC, RA Capital Management.
The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 investment rounds annually. The high activity for fund was in 2018. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. Deals in the range of 50 - 100 millions dollars are the general things for fund. Opposing the other organizations, this Venrock Healthcare Partners works on 9 percentage points less the average amount of lead investments.
Investments analytics
Analytics
- Total investments
- 66
- Lead investments
- 7
- Exits
- 28
- Rounds per year
- 1.20
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (59)
- Health Care (36)
- Therapeutics (27)
- Pharmaceutical (20)
- Medical (15) Show 17 more
- Investments by region
-
- United States (54)
- France (3)
- China (2)
- Canada (2)
- Bermuda (1) Show 2 more
- Peak activity year
- 2024
- Number of Unicorns
- 2
- Number of Decacorns
- 3
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 317M
- Group Appearance index
- 0.98
- Avg. company exit year
- 6
- Avg. multiplicator
- 2.15
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lycia Therapeutics | 13 May 2024 | Biotechnology, Health Care, Life Science | Late Stage Venture | 106M | United States, California, San Diego |
| Mythic Therapeutics | 15 Dec 2021 | Biotechnology, Health Care, Pharmaceutical, Therapeutics | Early Stage Venture | 103M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.